Amicizia D, Micale R, Pennati B, Zangrillo F, Iovine M, Lecini E
J Prev Med Hyg. 2020; 60(4):E271-E285.
PMID: 31967084
PMC: 6953460.
DOI: 10.15167/2421-4248/jpmh2019.60.4.1333.
Milligan R, Paul M, Richardson M, Neuberger A
Cochrane Database Syst Rev. 2018; 5:CD001261.
PMID: 29851031
PMC: 6494485.
DOI: 10.1002/14651858.CD001261.pub4.
Subhan M, Sadiq W
Cureus. 2018; 9(12):e1910.
PMID: 29441245
PMC: 5800782.
DOI: 10.7759/cureus.1910.
Amicizia D, Arata L, Zangrillo F, Panatto D, Gasparini R
J Prev Med Hyg. 2017; 58(1):E1-E8.
PMID: 28515625
PMC: 5432773.
Gibani M, Jin C, Darton T, Pollard A
Clin Infect Dis. 2015; 61 Suppl 4:S266-71.
PMID: 26449941
PMC: 4596929.
DOI: 10.1093/cid/civ673.
A review of typhoid fever transmission dynamic models and economic evaluations of vaccination.
Watson C, Edmunds W
Vaccine. 2015; 33 Suppl 3:C42-54.
PMID: 25921288
PMC: 4504000.
DOI: 10.1016/j.vaccine.2015.04.013.
Building the case for wider use of typhoid vaccines.
Crump J
Vaccine. 2015; 33 Suppl 3:C1-2.
PMID: 25910921
PMC: 4840404.
DOI: 10.1016/j.vaccine.2015.04.033.
Use of Ensure® nutrition shakes as an alternative formulation method for live recombinant Attenuated Salmonella Typhi vaccines.
Brenneman K, Gonzales A, Roland K, Curtiss 3rd R
BMC Microbiol. 2015; 15:76.
PMID: 25879849
PMC: 4391280.
DOI: 10.1186/s12866-015-0409-5.
A low gastric pH mouse model to evaluate live attenuated bacterial vaccines.
Brenneman K, Willingham C, Kilbourne J, Curtiss 3rd R, Roland K
PLoS One. 2014; 9(1):e87411.
PMID: 24489912
PMC: 3906194.
DOI: 10.1371/journal.pone.0087411.
Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA.
Muhsen K, Pasetti M, Reymann M, Graham D, Levine M
J Infect Dis. 2013; 209(9):1452-8.
PMID: 24273182
PMC: 3982847.
DOI: 10.1093/infdis/jit625.
Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa.
Feasey N, Dougan G, Kingsley R, Heyderman R, Gordon M
Lancet. 2012; 379(9835):2489-2499.
PMID: 22587967
PMC: 3402672.
DOI: 10.1016/S0140-6736(11)61752-2.
Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines.
Ohtake S, Martin R, Saxena A, Pham B, Chiueh G, Osorio M
Vaccine. 2011; 29(15):2761-71.
PMID: 21300096
PMC: 3062996.
DOI: 10.1016/j.vaccine.2011.01.093.
Vaccine development in Staphylococcus aureus: taking the biofilm phenotype into consideration.
Harro J, Peters B, OMay G, Archer N, Kerns P, Prabhakara R
FEMS Immunol Med Microbiol. 2010; 59(3):306-23.
PMID: 20602638
PMC: 2936112.
DOI: 10.1111/j.1574-695X.2010.00708.x.
Meeting on establishment of consortium to study invasive Salmonelloses in Sub-Saharan Africa.
Clemens J
Emerg Infect Dis. 2009; 15(7):e2.
PMID: 19624911
PMC: 5836488.
DOI: 10.3201/eid1507.090416.
Estimating the incidence of typhoid fever and other febrile illnesses in developing countries.
Crump J, Youssef F, Luby S, Wasfy M, Rangel J, Taalat M
Emerg Infect Dis. 2003; 9(5):539-44.
PMID: 12737736
PMC: 2972755.
DOI: 10.3201/eid0905.020428.
Differential production of interleukin-12 mRNA by murine macrophages in response to viable or killed Salmonella spp.
Chong C, Bost K, Clements J
Infect Immun. 1996; 64(4):1154-60.
PMID: 8606072
PMC: 173897.
DOI: 10.1128/iai.64.4.1154-1160.1996.
Intestinal immunoglobulin A responses in rabbits to a Salmonella typhi strain harboring a Shigella sonnei plasmid.
Keren D, Collins H, Baron L, Kopecko D, Formal S
Infect Immun. 1982; 37(1):387-9.
PMID: 7049953
PMC: 347539.
DOI: 10.1128/iai.37.1.387-389.1982.
[Intestinal Infections due to Campylobacter, Yersinia, Salmonella and Shigella].
Bull World Health Organ. 1980; 58(5):691-711.
PMID: 6975180
PMC: 2395988.
Enteric infections due to Campylobacter, Yersinia, Salmonella, and Shigella. WHO Scientific Working Group.
Bull World Health Organ. 1980; 58(4):519-37.
PMID: 6969131
PMC: 2395930.
Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
Johnson E, DIENA B, Lior H, Ryan A, Krol P, Baron L
Infect Immun. 1982; 38(1):201-5.
PMID: 6754614
PMC: 347719.
DOI: 10.1128/iai.38.1.201-205.1982.